SureTrader
Home > Boards > US Listed > Biotechs > Avid Bioservices Inc. (CDMO)

I don't know about the rest of you,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
pphmtoolong Member Profile
 
Followed By 27
Posts 3,644
Boards Moderated 0
Alias Born 07/17/06
160x600 placeholder
Avid Bioservices Announces Pricing of Public Offering of Common Stock GlobeNewswire Inc. - 2/15/2018 5:00:00 AM
Avid Bioservices Announces Proposed Offering of Common Stock GlobeNewswire Inc. - 2/14/2018 4:02:52 PM
Avid Bioservices and Oncologie Enter Into Asset Assignment and Purchase Agreement for Avid’s PS-Targeting Program Including... GlobeNewswire Inc. - 2/12/2018 8:05:00 AM
Avid Bioservices to Present at NobleCon14 GlobeNewswire Inc. - 1/23/2018 8:05:00 AM
Peregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development a... GlobeNewswire Inc. - 1/5/2018 8:05:00 AM
Peregrine Pharmaceuticals to Present at Biotech Showcase 2018 GlobeNewswire Inc. - 1/2/2018 8:05:00 AM
Peregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive Officer GlobeNewswire Inc. - 12/26/2017 8:05:00 AM
Peregrine Pharmaceuticals Reports Financial Results for Second Quarter of Fiscal Year 2018 and Recent Developments GlobeNewswire Inc. - 12/11/2017 4:05:00 PM
Peregrine Pharmaceuticals Declares Quarterly Dividend on its Series E Convertible Preferred Stock GlobeNewswire Inc. - 12/7/2017 4:05:00 PM
Peregrine Pharmaceuticals to Report Financial Results for Second Quarter of Fiscal Year 2018 After Market Close on December 1... GlobeNewswire Inc. - 12/4/2017 4:05:00 PM
Avid Bioservices Announces Appointment of Tracy Kinjerski as Vice President of Business Operations GlobeNewswire Inc. - 11/29/2017 8:05:00 AM
Peregrine Pharmaceuticals, Ronin Trading and SW Investment Management Announce Settlement Agreement GlobeNewswire Inc. - 11/28/2017 8:05:00 AM
Peregrine Announces Date of 2017 Annual Meeting of Stockholders GlobeNewswire Inc. - 11/13/2017 8:05:00 AM
Ronin Trading and SW Investment Management Release Presentation Highlighting Concerns with Board of Peregrine Pharmaceuticals PR Newswire (US) - 10/30/2017 11:54:00 AM
Ronin Trading And SW Investment Management Announce Additional Nominations To Board Of Peregrine Pharmaceuticals PR Newswire (US) - 10/27/2017 8:30:00 AM
Peregrine Pharmaceuticals Announces Appointment of Patrick Walsh to Board of Directors of Peregrine and Avid Bioservices GlobeNewswire Inc. - 10/24/2017 8:05:00 AM
Peregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid Bioservices GlobeNewswire Inc. - 10/19/2017 8:05:00 AM
Ronin Trading and SW Investment Management Announce Additional Nomination to Board of Peregrine Pharmaceuticals PR Newswire (US) - 10/10/2017 12:59:00 PM
CORRECTING and REPLACING Announcing VanEck Vectors Equity ETF’s September 2017 Distributions Business Wire - 10/2/2017 12:35:00 PM
Announcing VanEck Vectors Equity ETF’s September 2017 Distributions Business Wire - 9/29/2017 5:25:00 PM
Avid Bioservices Expands Manufacturing Capabilities With Installation and Validation of Two MilliporeSigma Mobius® 2,000-Lit... GlobeNewswire Inc. - 9/25/2017 8:05:00 AM
Biotech's Recently Under the Microscope, Analyst Coverage InvestorsHub NewsWire - 9/20/2017 8:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/19/2017 2:51:59 PM
Avid Bioservices to Exhibit at 2017 BioProcess International Conference & Exhibition GlobeNewswire Inc. - 9/19/2017 8:05:00 AM
pphmtoolong   Tuesday, 04/24/12 10:44:52 AM
Re: None
Post # of 324903 
I don't know about the rest of you, but I bought this stock based on Thorpe's approved patents and the early Bavi clinical studies.

It seems that Peregrine management and BOD have done everything reasonable to forward the Bavi agenda given the limited financial resources available. Running the trials overseas in Georgia and India could not have been easy, but they did it and got promising results. As in many other cases Bavi may not pan out in later stage trials. I don't blame management for trying with Bavi, and I don't blame management for the perversity of Mother Nature. I could blame them for excessive optimism, but the science seemed sound to them just as it seemed sound to us.

I don't like that managment has diluted the heck out of our stock, but I really don't buy any of the alternative financing plans I've seen presented here. I am a retired CPA; so I have some confidence assessment on this point.

If Bavi finally hits it out of the park with second line NSCLC, there is still a chance for us to make money. Otherwise, this has been a very expensive lesson in wishful thinking on biotechs. I blame only myself if Peregrine flops. I never should have thrown so much money into such a crap shoot.

Paul


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist